J Reconstr Microsurg
DOI: 10.1055/a-2717-4388
Original Article

Investigation of Routine Venous Augmentation in Deep Inferior Epigastric Artery Perforator Flap and Intraoperative Decision Pathway

Authors

  • Anne M. Meyer

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Cole Bird

    2   University of Kansas Medical School, Kansas City, Kansas, United States
  • Niaman Nazir

    3   Department of Population Health, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Meredith Collins

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Rebecca Farmer

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Eric Lai

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • James Butterworth

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States
  • Julie Holding

    1   Department of Plastic, Burn, and Wound Surgery, University of Kansas Medical Center, Kansas City, Kansas, United States

Abstract

Background

Data supporting use of prophylactic venous augmentation in the deep inferior epigastric perforator flap (DIEP) is limited. This study aims to assess the outcomes of single vein DIEP flaps compared with those with venous augmentation and present an intraoperative decision pathway.

Methods

A retrospective chart review was performed on patients who underwent DIEP flap reconstruction at a single institution from 2009 to 2023. Statistical analysis was performed and p-values less than 0.05 were considered statistically significant.

Results

A total of 1,099 patients had DIEP flap breast reconstruction resulting in 1,745 flaps. Two or more veins were utilized in 32.4%, whereas 67.6% had a single venous anastomosis. Prophylactic augmentation was documented for 24.5% of flaps. The rate of return to operating room was 5.8% with no significant difference found in the rate of return for all causes (p = 0.14) and suspected venous compromise (p = 0.95). Suspected venous compromise was documented in 41flaps (2.3%), with no significant difference between the single vein and prophylactic vein group (p = 0.95). There was no difference in rates of early (p = 0.10) or late flap loss (p = 0.15). Difference in operative duration was increased for flaps with prophylactic venous anastomoses (559.4 ± 127.8 vs. 505.6 ± 130.8 minutes; p < 0.001).

Conclusion

This study demonstrates no significant difference in postoperative complications as well as demonstrating prophylactic multivein anastomosis was associated with significantly longer operative times. With the use of an intraoperative decision pathway, one can determine which flaps will benefit from additional venous outflow and avoid unnecessary routine augmentation without benefit.



Publication History

Received: 12 April 2025

Accepted: 21 September 2025

Accepted Manuscript online:
09 October 2025

Article published online:
11 November 2025

© 2025. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA